CBT-based and Motivational Interviewing Supported Psychoeducation in Obese Individuals

February 27, 2026 updated by: Yusuf Durmuş, Inonu University

The Effect of Cognitive Behavioral Therapy-Based and Motivational Interviewing-Supported Psychoeducation on Emotional Eating and Psychological Resilience in Individuals With Obesity

The aim of this study is to examine the effects of cognitive-behavioral and motivational interview-supported psychoeducation on emotional eating and psychological resilience in obese individuals. The study will be conducted with a randomized controlled experimental design. The sample of the study will consist of 102 obese individuals in total, 51 in the experimental group and 51 in the control group, who meet the inclusion criteria. A cognitive-behavioral and motivational interview-supported psychoeducation program will be applied to the experimental group. All patients will be evaluated at three time points: pre-test (baseline), post-test (8 weeks), and follow-up test (3 months after the post-test). No intervention will be applied to the control group. The Emotional Eating Scale and Psychological Resilience Scale will be used as data collection tools in the study. As a result of the study, the hypothesis that the cognitive-behavioral and motivational interview-supported psychoeducation program is effective in reducing the emotional eating levels of obese individuals and increasing their psychological resilience levels will be tested. The findings of the study will contribute to the importance and effectiveness of psychological approaches in the treatment of obesity.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

81

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey (Türkiye)
    • Muş
      • Muş, Muş, Turkey (Türkiye), 49000
        • Muş State Hospital and Muş Central Healthy Life Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Obese individuals (body mass index 30 kg/m2 or more)
  • Between the ages of 18-65
  • Not having any psychiatric disorder or not using psychiatric medication
  • Volunteering to participate in psychoeducation
  • Being in a physical and mental condition that will allow them to adapt to treatment
  • Signing the informed consent form

Exclusion Criteria:

  • Having communication problems
  • Having a medical condition (e.g. Cushing syndrome, hypothyroidism) or taking medication that causes obesity
  • Having a psychiatric diagnosis (e.g. depression, anxiety disorder, eating disorder) or taking psychotropic medication
  • Being pregnant or breastfeeding
  • Participating in another diet or exercise program

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Psychoeducation Group
Obese individuals in this group receive the structured cognitive behavioral therapy-based and motivational interviewing-supported psychoeducation program.
Behavioral: Cognitive Behavioral Therapy- Based and Motivational Interviewing-Supported Psychoeducation
An 8-week structured psychoeducation program based on cognitive behavioral therapy principles and supported by motivational interviewing techniques.
No Intervention: Control Group
Obese individuals in this group did not receive any interventional procedure during the study period. Only assessment measurements were conducted for research purposes. After completion of follow-up assessments, the psychoeducation program was offered to those who requested it.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Emotional Eating Scale
Time Frame: Baseline; end of week 8 (post-intervention); 2-month follow-up
Emotional eating was assessed using the Emotional Eating Scale (EES). Scores range from 0 to 30; higher scores indicate a worse outcome (greater emotional eating).
Baseline; end of week 8 (post-intervention); 2-month follow-up
Resilience scale
Time Frame: Baseline; post-intervention (end of week 8); 2-month follow-up
Resilience was assessed using a resilience scale. Scores range from 0 to 84; higher scores indicate greater resilience (better outcome).
Baseline; post-intervention (end of week 8); 2-month follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Inonu University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 25, 2024

Primary Completion (Actual)

June 5, 2025

Study Completion (Actual)

August 5, 2025

Study Registration Dates

First Submitted

October 6, 2024

First Submitted That Met QC Criteria

October 6, 2024

First Posted (Actual)

October 8, 2024

Study Record Updates

Last Update Posted (Actual)

March 3, 2026

Last Update Submitted That Met QC Criteria

February 27, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Durmusobe

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe